<DOC>
	<DOC>NCT00569101</DOC>
	<brief_summary>The purpose of this protocol is to determine whether Tacrolimus and Prednisolone are effective and safe in the treatment of the cyclophosphamide-resistant, refractory diffuse proliferative lupus nephritis</brief_summary>
	<brief_title>A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis</brief_title>
	<detailed_description />
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Biopsyproven lupus nephritis WHO Class IV , IV+V Previously treated by three times over of i.v. cyclophosphamide or 6 months more duration of immunosuppressive treatments (azathioprine, MMF, cyclophosphamide p.o.) for the lupus nephritis spot urine Protein creatinine raio &gt; 1.0 RBC &gt; 5 /HPF on microscopic examination of urine previous treatment of cyclosporine A or tacrolimus serum Creatinine lever : over 300 mmol/dl allergy to the macrolide antibiotics other systemic organ damage</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>